Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 1ACITRETIN
02 1ALLEGRA
03 1ALLEGRA ALLERGY
04 1ALLEGRA HIVES
05 2APREPITANT
06 3CHILDRENS ALLEGRA ALLERGY
07 3CHILDRENS ALLEGRA HIVES
08 1CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY
09 1CHILDRENS FEXOFENADINE HYDROCHLORIDE HIVES
10 1CINACALCET HYDROCHLORIDE
11 1DEFERASIROX
12 1DULOXETINE HYDROCHLORIDE
13 1EXELDERM
14 1FAMCICLOVIR
15 1FENOFIBRATE
16 11GABAPENTIN
17 1ISENTRESS
18 1ISENTRESS HD
19 1LOTEMAX SM
20 1METHADOSE
21 1OMEPRAZOLE
22 1OTIPRIO
23 2RALOXIFENE HYDROCHLORIDE
24 1REPAGLINIDE
25 2SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
26 1ZMAX
01 117116
02 118738
03 420872
04 221909
05 121963
06 222145
07 150797
08 173630
09 174449
10 175576
11 177662
12 178782
13 178926
14 190335
15 190705
16 190842
17 191480
18 191517
19 2201373
20 1202045
21 1202148
22 1203244
23 2203330
24 1204491
25 1204989
26 1205101
27 1205118
28 1206402
29 1207777
30 1207986
31 1208219
32 1209306
33 1210548
34 1211383
35 1211835
36 1217995
01 37No
02 6Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : RALOXIFENE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 204491
Country : US
Patented : No
Drug : APREPITANT
Dosage Form : CAPSULE; ORAL
Application Number : 207777
Country : US
Patented : No
Drug : EXELDERM
Dosage Form : SOLUTION; TOPICAL
Application Number : 18738
Country : US
Patented : No
Drug : DEFERASIROX
Dosage Form : TABLET; ORAL
Application Number : 211383
Country : US
Patented : No
